Hagerman, R., Jacquemont, S., Berry-Kravis, E., Portes, V. D., Stanfield, A., Koumaras, B., . . . Raison, F. v. (2018). Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents. Nature Portfolio.
Cita Chicago Style (17a ed.)Hagerman, Randi, et al. Mavoglurant in Fragile X Syndrome: Results of Two Open-label, Extension Trials in Adults and Adolescents. Nature Portfolio, 2018.
Cita MLA (8a ed.)Hagerman, Randi, et al. Mavoglurant in Fragile X Syndrome: Results of Two Open-label, Extension Trials in Adults and Adolescents. Nature Portfolio, 2018.
Precaución: Estas citas no son 100% exactas.